Bayer and Janssen Face Patent Lawsuits over Xarelto Centralized in Delaware
The realm of pharmaceuticals often encounters complex disputes surrounding intellectual rights and innovations. These conflicts can significantly impact both the companies involved and the patients relying on their products. A notable instance arises from ongoing controversies that have led to the consolidation of various disputes within a specific jurisdiction, creating a focal point for resolution … Read more